PLATINUM

BioSpring

BioSpring is a leading CMO for therapeutic oligonucleotides. Our manufacturing facilities include small scale capabilities for research and development up to large scale in several 100 kg quantities for therapeutic use. We offer all services necessary for APIs, starting from early process development to process validation as well as all related analytical services such as release testing, analytical method development/validation, stability studies, drug product testing. In addition, we offer a wide range of analytical services for oligonucleotide drug products. BioSpring is cGMP certified by the German authorities for more than 12 years and passed 2 successful FDA inspections for its QC laboratories.

PLATINUM

Nitto Denko Avecia Inc.

With over 20 years of experience in oligonucleotide development and production, and over 1000 sequences manufactured, Nitto Denko Avecia Inc. is a leader in the advancing oligo therapeutic market. Our mission is to continue to build value for our customers as they progress through drug development into commercialization.

GOLD

Bachem

Bachem is specialized in the process development and manufacturing of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe, the US and Asia, the group has a global reach and towards its customers, Bachem shows total commitment to quality, innovation and partnership.
Bachem. Pioneering Partner for Peptides

GOLD

CordenPharma

CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products and associated Packaging Services. Through a network of cGMP facilities across Europe and the US organized under five technology platforms – Peptides, Lipids & Carbohydrates – Injectables – Highly Potent & Oncology – Small Molecules – Antibiotics – CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products.

GOLD

CSBio

CSBio is a leading peptide and instrumentation manufacturing company based in Silicon Valley in Menlo Park, California.
For over 25 years, CSBio has been providing high quality custom peptides, cGMP peptides, and automated peptide synthesizers to the global biotech community. Our peptide products and instrumentation can be found in production laboratories and pharmaceutical companies worldwide.
We have state of the art cGMP manufacturing facilities to take you from tox studies through market commercialization, and we’ve recently launched a proven line of oligonucleotide synthesizers for small scale R&D to large scale manufacturing.

GOLD

Dr. Reddy’s

Dr. Reddy’s is committed to provide affordable and innovative medicines for healthier lives. As a global full service CDMO, our Custom Pharma Services (CPS) unit provides pharmaceutical companies with integrated development and manufacturing services of APIs and finished dosages including peptides, highly potent and oncology products. Our peptides capabilities include cost effective cGMP characterization, development, synthesis and purification from milligram to kilogram.

GOLD

Olon

Olon is one of the largest developers and manufacturers supplying APIs to industries worldwide to both Generic and CDMO market.
With more than 230 APIs for the Generic market and 33 chemical intermediates (under CMO) is holder of about 155 active US DMFs and 69 granted CoS.
Headquartered in Rodano (Italy), Olon has 11 manufacturing facilities: 8 in Italy, 1 in Spain, 1 in USA and 1 in India, and 3 branch offices in Germany, USA, China.
The manufacturing sites are regularly inspected by FDA and the most important national and international Authorities, and audited by our partners and customers.

GOLD

PolyPeptide Group

The PolyPeptide Group is a privately-held group of manufacturing sites which focus on proprietary and generic GMP-grade peptides for the pharmaceutical and biotechnological market. With more than 60 years of experience, the Group is committed to the highest quality of peptide manufacturing for commercial peptide drug substances, GMP peptides in clinical trials, or small-scale non-GMP custom syntheses.
The Group has manufacturing facilities in Belgium (Braine L’Alleud), Sweden (Malmo), France (Strasbourg), India (Ambernath) and two sites in the USA (San Diego CA & Torrance CA). As a multinational company with about 800 employees worldwide, its diversity brings breadth and depth of knowledge and experience to the Group.
The Group's long-established core strength in GMP manufacturing and broad range of services supports peptide & peptide-like projects, including conjugation to non-peptide moieties, from the bench through to commercialization. With continually increasing capacity for GMP manufacturing, the PolyPeptide Group is stronger and better equipped to serve the needs of its customers at all stages of pharmaceutical peptide development. With its multinational organization, strict focus on peptides and solid financial base, the Group offers an almost unique security of supply to its customers.

GOLD

Purolite® Life Sciences

Purolite Life Sciences brings Purolite’s innovative thinking and distinguished history of resin technology expertise to the global Life Sciences marketplace. Over three decades, Purolite has grown into the world’s premier resin technology manufacturer and innovation leader, with production plants and advanced research labs across the globe.
Purolite Life Sciences provides API’s, enzyme carriers and immobilized enzymes, and resins for purification and separation to support research and development, and production-scale applications in pharmaceuticals, protein purification, food production, bioprocessing, fine chemical and additional markets. With a team of world-class researchers and scientists, we develop novel, high-demand and customized products to meet customer needs.

GOLD

Tosoh Bioscience

Tosoh Bioscience is an acknowledged global leader in liquid chromatography with a focus on bioseparations. We are providing cutting-edge solutions for customers developing and manufacturing biologics, biosimilars or biobetters. Our portfolio encompasses a comprehensive line of media and U/HPLC columns used in R & D, process development, production, and QC. Typical applications comprise the purification of therapeutic proteins at lab, pilot, and commercial scale, as well as their characterization or quality control. Tosoh Bioscience is part of the Tosoh Group, a Japanese chemical and specialty products group with over 100 companies worldwide and a workforce of more than 12000 people.

SILVER

emp BIOTECH

emp Biotech is a European manufacturer of reagents and consumables for use in oligonucleotide synthesis – at scales ranging from small-scale R&D to large-scale cGMP therapeutics manufacturing.
The product range includes all of the commonly used solvent mixtures, high quality crystalline activators, purification (desalting and ion exchange) solid phases and solvent drying bags. Additionally, we are proud to be Hongene’s European distributor of phosphoramidite products.
Products are available in standard packs as well as fully customised solutions, including custom solvent formulations.

SILVER

Gyros Protein Technologies

Gyros Protein Technologies, enables peptide synthesis and bioanalytical solutions that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. Our low- to mid-scale peptide synthesizer platforms are PurePep™ Chorus, Tribute®, Prelude® X, Symphony® X, and Sonata® XT. These solutions and our chemistries deliver uncompromising purity, flexibility, and quality for discovery and pre-clinical studies of simple to complex multifunctional peptides. Gyros Protein Technologies is a division of Mesa Laboratories.

SILVER

Iris Biotech

Iris Biotech specializes in reagents for Drug Discovery, Drug Delivery, and Diagnostics. We have know-how and production capabilities to manufacture and supply products for following areas:
1. Starting Materials for Peptide Synthesis, Peptidomimetics and Medicinal Chemistry.
2. Technologies for Drug Delivery.Worldwide largest portofolio of PEGylation reagents, selection of certain Poly(amino acids). Different ADC linkers.
3. Reagents for Life Sciences and Diagnostics.
We are carrying out Contract Manufacturing projects in these areas. Our strong points are unusual derivatives with one or several chiral centers.

SILVER

Kinovate Life Sciences

Kinovate Life Sciences is a leading provider of solid supports for the oligonucleotide therapeutic industry. KLS’s proprietary solid supports Nittophase® and Nittophase®HL, with conventional and custom loadings of up to 400mmol/g, have proven superior performance in synthesis scales from mmol to hundreds of mmols, increasing synthesis yields and improving impurity profiles. NittoPhase® and NittoPhase® HL loaded solid supports are manufactured under cGMP guideline.

SILVER

Quality Assistance

Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products.

With more than 35 years’ experience, Quality Assistance has become a leader in analytical sciences and holds a unique position on the market with all its laboratories on one site and 190 highly qualified professionals.

We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.

For more information, meet us at our stand and visit our website

SILVER

WuXi AppTec

WuXi AppTec, a leading pharmaceutical and medical device open-access capability and technology platform company with global operations. An innovation-driven and customer-focused company, WuXi AppTec enables biotech and pharmaceutical innovators through our one-stop-platform for discovery (WuXi RSD) through GMP API and drug product production (WuXi STA) for Oligonucleotide therapies.

IN COLLABORATION WITH

University of Barcelona

The University of Barcelona is the most formidable public institution of higher education in Catalonia, catering to the needs of the greatest number of students and delivering the broadest and most comprehensive offering in higher educational courses. The UB is also the principal centre of university research in Spain and has become a European benchmark for research activity, both in terms of the number of research programmes it conducts and the excellence these have achieved.
Its own history closely tied to the history of Barcelona and of Catalonia, our university combines the values of tradition with its position as an institution dedicated to innovation and teaching excellence: a university that is as outward-looking and cosmopolitan as the city from which it takes its name.

IN COLLABORATION WITH

University of Milan

The University of Milan, founded in 1924, is a public institution that has a proactive role in science, technology and economics networks. It was one LERU co-founders and is the only Italian University to be a member of the organisation. The University of Milan is involved in several national and international research programs and has also strengthened its efforts to promote technology transfer, a growth area offering exciting new changes and challenges. The results of its research, attested to by an important quantity of scientific publications, have allowed it to obtain the top positions in the most authoritative international rankings. The research at the Department of Pharmaceutical Sciences covers a range of activities focused on the design, synthesis, development, and control of novel biologically active molecules, and of new pharmaceutical drug delivery systems, food supplements, cosmetics, biocides and medical devices. The goals are those of improving knowledge in the field of basic research, a major cultural investment to design a qualified research aimed at the discovery of novel drugs and able to boost an efficient technology transfer.

IN COLLABORATION WITH

Politecnico di Milano

Politecnico di Milano, founded in 1863, is a scientific-technological university which trains engineers, architects and industrial designers. The University has always focused on the quality and innovation of its teaching and research, developing a fruitful relationship with business and productive world by means of experimental research and technological transfer. Research has always been linked to didactics and it is a priority commitment which has allowed Politecnico Milano to achieve high quality results at an international level as to join the university to the business world. Research constitutes a parallel path to that formed by cooperation and alliances with the industrial system. Dipartimento di Chimica, Materiali e Ingegneria Chimica “Giulio Natta” (DCMIC) is the center of the “chemical culture” within the Politecnico di Milano. The DCMIC mission is to conduct high-quality research in the fields of chemistry, chemical engineering, science and materials engineering and bioengineering, promoting their central role in all the new technologies involving matter and energy transformation. Nanomedicine, drug delivery, biomaterials and technologies, pharmaceutical processes are among core interests at DCMIC.